相关实验视频

Updated: Apr 16, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

用循环瘤细胞绘制乳腺癌治疗的地图:专家的观点

Lorenzo Gerratana¹, Caterina Gianni², Eleonora Nicolò³

¹Department of Medical Oncology, CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy; Department of Medicine, University of Udine, Udine, Italy.

Breast (Edinburgh, Scotland)

|April 6, 2025

概括

循环瘤细胞 (CTC) 是转移性乳腺癌中重要的预后生物标志物. 对CTC的计数和分子特征指导个性化治疗策略,改善患者的治疗结果.

科学领域:

在瘤学瘤学.
生物标志物生物标志物
液体活检液体活检

背景情况:

循环瘤细胞 (CTC) 是乳腺癌的确立预后生物标志物,特别是在转移性疾病中.
CTC计数 (≥5细胞/7.5毫升血液) 与侵袭性第四阶段疾病和较差的存活率相关.
对CTCs的分子表征提供了对瘤生物学和变异性的实时洞察.

研究的目的:

审查CTC计数和表型化在乳腺癌管理中的作用.
探索CTC指导的策略如何提高治疗量身定制和患者的结果.
为了检查CTC与其他生物标志物的整合,例如循环瘤DNA (ctDNA) 进行个性化医疗.

主要方法:

关于乳腺癌中CTC计数和分子特征的现有文献的综述.
对临床试验数据 (例如STIC试验) 的分析,证明CTC引导的治疗调整.
探索涉及CTC和ctDNA的组合生物标志物策略.

主要成果:

CTC计数可靠地将转移性乳腺癌分为攻击性和惰性亚型.
对CTCs的分子分析提供了对瘤异质性的动态见解.
以CTC为指导的治疗有可能优化治疗强度和疗效.

结论:

CTC对于转移性乳腺癌的预后和指导治疗至关重要.
将CTC编目和表型与ctDNA等其他生物标志物的整合可以推进个性化治疗.
生物标志物驱动的临床试验设计对于通过先进的液体活检技术优化患者护理至关重要.

关键词:

乳腺癌乳腺癌乳腺癌循环中的瘤细胞.液体活检液体活检精准医学是一门精准的医学.

更多相关视频

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model

Published on: October 9, 2015

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.